TERN
Terns Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$52.95
−0.03%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+33.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 2, 2026 | Kuriakose Emil · officer: Chief Medical Officer | Sale | 942 | $53 |
| Mar 17, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 11,813 | $47 |
| Mar 17, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 2,770 | $47 |
| Mar 17, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 14,583 | $4.64 |
| Feb 18, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 2,341 | $38 |
| Feb 18, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 14,583 | $4.64 |
| Feb 18, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 4,083 | $40 |
| Feb 18, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 8,159 | $39 |
| Feb 2, 2026 | Turner Heather D · director | A-Award | 1,697 | $35 |
| Feb 2, 2026 | Tripuraneni Radhika · director | A-Award | 1,697 | $35 |
| Feb 2, 2026 | Azelby Robert · director | A-Award | 1,697 | $35 |
| Feb 2, 2026 | Quigley Jill M. · director | A-Award | 1,697 | $35 |
| Feb 2, 2026 | KINDLER JEFFREY B · director | A-Award | 1,697 | $35 |
| Feb 2, 2026 | FELLOWS DAVID A · director | A-Award | 2,828 | $35 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 27,083 | $4.64 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 14,583 | $4.64 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | A-Award | 300,000 | $37 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 61,228 | $37 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | A-Award | 150,000 | $0.00 |
| Jan 16, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 7,521 | $38 |
| Jan 16, 2026 | Gengos Andrew · officer: Chief Financial Officer | A-Award | 68,750 | $0.00 |
| Jan 16, 2026 | Gengos Andrew · officer: Chief Financial Officer | A-Award | 137,500 | $37 |
| Jan 16, 2026 | Kuriakose Emil · officer: Chief Medical Officer | A-Award | 56,250 | $0.00 |
| Jan 16, 2026 | Kuriakose Emil · officer: Chief Medical Officer | A-Award | 112,500 | $37 |
| Jan 6, 2026 | Kuriakose Emil · officer: Chief Medical Officer | Sale | 955 | $38 |
| Jan 6, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 21,551 | $4.64 |
| Jan 6, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | M-Exempt | 150,000 | $0.00 |
| Jan 6, 2026 | Burroughs Amy L. · director, officer: Chief Executive Officer | Sale | 71,339 | $38 |
| Jan 6, 2026 | Kuriakose Emil · officer: Chief Medical Officer | Sale | 200 | $40 |
| Nov 5, 2025 | Quigley Jill M. · director | M-Exempt | 24,520 | $9.24 |
Institutional positioning
13F filings over the trailing two quarters
New 136Increased 118Reduced 57Sold out 319
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 9,569,585 | May 13, 2026 |
| MORGAN STANLEY | Reduced | 6,449,140 | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 5,695,000 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,355,482 | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | New Position | 4,350,000 | Mar 16, 2026 |
| HOLOCENE ADVISORS, LP | Increased | 4,115,828 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 3,887,445 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 3,747,310 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,393,358 | May 15, 2026 |
| HBK INVESTMENTS L P | New Position | 2,950,000 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 2,869,728 | May 13, 2026 |
| LORD, ABBETT & CO. LLC | Increased | 2,812,938 | May 14, 2026 |
| IKARIAN CAPITAL, LLC | Increased | 2,656,378 | May 15, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 2,409,019 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2,316,544 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 2, 2026